NatWest Markets Strategy & Sales

NWM: IBOR Reform: Ringing the bell for the end of term?
Phil Lloyd
17 March 2019 09:54


Authors
Phil Lloyd
Head of Market Structure & Regulatory Customer Engagement
London
+44 20 7085 1271

Contributors
{{contributor-span-repeater}}

As reiterated by the FCA last month, the production of LIBOR is likely to end in 2021 and all markets need to transition to the replacement Risk Free Rates (RFRs) or face ‘chaos’….

  

The GBP FRN market has fully and consistently embraced the new world of RFRs with over £16bn of SONIA referenced issuance; all using the same daily compounded rate and a five day reset lead. Before the first issuance by the EIB, the market was sceptical on the practicalities of a daily reset but we now have a market of 18 global issuers with a continually growing investor base.  The infrastructure works and liquidity in SONIA FRNs is comparable to legacy LIBOR instruments. To date, there has been no corporate issuance, but corporate GBP FRNs have always been rare.  One corporate, Associated British Ports, is working to amend their two outstanding FRNs to SONIA, with NatWest Markets as the advisor.

  

But where is the loan market??? So far there has been no evidence of SONIA loans and much is made of the need for a term rate, similar to where the FRN market was 12 months ago.

  

Are term rates needed for new loans and what could be the impact with and without them?

  

What is the issue with term rates?

  

On the face of it, a term SONIA rate could make the loan market transition relatively simple.  Systems could change their reset feed and most documentation terms would be unchanged. Margins would likely need to change to reflect the loss of term premium, but pricing for the change could be transparent and utilise the LIBOR vs SONIA basis swap, as seen in the FRN market.

  

There are clear downsides though.  A term SONIA rate could be based on a market observed rate such as the fixed rate on an interest rate swap vs SONIA (e.g. the 3 month Overnight Index Swap or OIS) - this rate moves intra-day and would need to be observed using a public fixing.  Regulators will need to be comfortable that sufficient protections are embedded into financial markets to ensure that conflicts of interest and manipulation risks are removed (how different is that to LIBOR?). Yes a liquid market helps but what about illiquid days?  Easter Thursday, Christmas Eve and even some summer days see very little trading.

  

This has even bigger impacts on derivative trading too. A swaps trader currently makes markets and prices in OIS as well as LIBOR swaps. If that trader is then quoting on OIS and managing swaps which use the OIS fixing as their floating index, this creates a clear conflict of interest.

  

In light of these points, in November 2018, the Working Group on Sterling Risk-Free Reference Rates stated that “Finding ways to avoid the systematic usage of TSRRs (Term SONIA Reference Rates) in derivatives markets will be essential as TSRRs develop”.

  

Given that the daily SONIA market for bonds and derivatives is likely to be bigger‎ than that for term SONIA, the risk is that some firms will avoid the latter to avoid the regulatory costs and litigation risk. There is also a question of whether all users will be able to use term rates, or whether they will only be allowed in specific situations.  For those using term SONIA, liquidity could be low and costs could rise.  Who remembers the Betamax vs VHS format war in the 80's? Although Betamax was preferred by some, the more efficient VHS market created pricing that led to it emerging as the preeminent format.  Some readers may have never even heard of Betamax.

  

There is also the risk that there is more than one term rate available.  The publication of such rates could rely on private administrators and so we shouldn’t assume that only one benchmark will be released.  Multiple versions could further impact liquidity and it may be difficult for product providers and advisors to offer / recommend one over the other.

  

Is daily SONIA manageable for the loan market?

  

The derivative and FRN markets both use a compounded daily SONIA rate and so a loan product that was aligned to this would be helpfully consistent.

  

The biggest concern around daily SONIA is the lack of certainty on interest payments until towards the end of the period. These concerns are appreciated but we encourage a review of the actual volatility in a compounded SONIA.  Central banks have been very careful not to shock the market and forward guidance is now viewed as a critical part of their approach, making unexpected large changes in an interest period less likely.  In addition, changes will have a blended impact due to the averaging nature as seen in the second half of 2018 when the BoE hiked by 25bps.

  

  

The August 2018 25bps hike led to a rise in 6 month Compounded Daily SONIA in December of less than 20bps

Source: NatWest Markets

  

Short term pain for long term gain?

  

There are ways to manage such risks and technology could play a key role.  Technology for short dated FX hedging has evolved massively in recent years with online platforms reducing execution and operational costs dramatically.  Such platforms are used by all customer types, including the smallest corporates.

  

Could such platforms be extended to allow customers to easily hedge their short term SONIA reset risk using interest rate swaps?  If so then this would give increased flexibility compared to the current LIBOR world - you could fix your loan payments to a specific date rather than 1m, 3m or 6m. Yes there would be some work and execution costs every time the decision to fix was made, but in an efficient market with efficient technology these may be manageable in the same way that FX trades already are.

  

A compounded rate would require system improvements for many.  Daily compounded SONIA has a relatively simple formula but given it only compounds on business days and would likely have an extended reset lead, some work would be required – our experience in the FRN market tells us this is possible though.

  

There are benefits to the underlying loan document too.  LIBOR loans have break costs if they are pre-paid intra-period (a function of the LIBOR locked in vs the LIBOR for the remaining term) but a daily SONIA loan shouldn’t require them and could be drawn and repaid for any specific period within operational realism.  In addition, as a BoE published rate, SONIA has its own fallbacks embedded, removing the need for bespoke terms involving reference banks and future proofing from the unlikely event that we have to reform benchmarks ever again!

  

In summary

  

We expect a SONIA loan product to gain increasing interest in 2019.  There are clear benefits to daily compounded rates and if the market can embrace them from the outset we could avoid the risk of being in a Betamax situation and better still, if the pace of innovation is fast enough we could skip straight to streaming video!

  


This is Non-Independent Research, as defined by the Financial Conduct Authority.This material should be regarded as a marketing communication and may have been produced in conjunction with the NatWest Markets Plc trading desks that trade as principal in the instruments mentioned herein. All data is accurate as of the report date, unless otherwise specified.

 

This communication has been prepared by NatWest Markets Plc, and should be regarded as a Marketing Communication, for which the relevant competent authority is the UK Financial Conduct Authority.   Please follow the link for the following information https://www.natwestmarkets.com/natwest-markets/regulation/mar-disclosures.html   

  


Where communicated in Singapore, this communication may be deemed an advertisement. This advertisement has not been reviewed by the Monetary Authority of Singapore.  

  

  • MAR Disclaimer
  • Conflicts of Interest statement
  • Glossary of definitions
  • Historic Trade ideas log  

Phil Lloyd

Managing Director, NWM Sales

+44 20 7085 1271


 

This material is intended for your sole use and is provided to you on the understanding that, before entering into any transaction referred to in this material, and/or any related transaction (together, the “Transaction”), you will ensure that you fully understand the potential risks and return of the Transaction and determine whether the Transaction is appropriate for you given your objectives, experience, financial and operational resources, and other relevant circumstances. Nothing in this material constitutes an offer or invitation to enter into any engagement or transaction or an offer or invitation for the sale, purchase, exchange or transfer of any securities or a recommendation to enter into any transaction, nor is it intended to form the basis of any investment decision. None of NatWest Markets Plc, NatWest Markets N.V. (and/or any branches), NatWest Markets Securities Inc. and/or their affiliates (“NatWest Markets”) is soliciting any specific action based on this material. The material does not take into account the particular investment objectives, financial conditions, or needs of individual clients or whether any transaction is suitable for any particular investor. The remuneration of the author(s) is not directly tied to any transactions performed, or trading fees received, by any entity of the NatWest Group, for example, through the use of commission-based remuneration arrangements.

 

This material has been prepared by NatWest Markets and has not been prepared in accordance with the legal and regulatory requirements designed to promote the independence of investment research, and is not subject to any prohibition on dealing ahead of its dissemination. Any views expressed may differ from those of other business units of NatWest Markets. The opinions, commentaries, forecasts, assumptions, estimates, derived valuations and target price(s) or other statements contained in this communication (the “Views”) are valid as at the date and/or time indicated and are subject to change at any time without prior notice. NatWest Markets does not undertake to update you of such changes. Views expressed herein are not intended to be, and should not be viewed as advice or as a personal recommendation. The Views may not be objective or independent of the interests of the authors or other NatWest Markets trading desks, who may be active participants in the markets, investments or strategies referred to in this material. NatWest Markets will not act and has not acted as your legal, tax, regulatory, accounting or investment adviser; nor does NatWest Markets owe any fiduciary duties to you in connection with the Transaction and no reliance may be placed on NatWest Markets for investment advice or recommendations of any sort. You should make your own independent evaluation of the relevance and adequacy of the information contained in this document and make such other investigations as you deem necessary including obtaining independent financial advice, before participating in any transaction in relation to the securities referred to in this document. This material is not intended for distribution to, or use by any person or entity in any jurisdiction or country where such distribution or use would be contrary to local law or regulation. The information contained herein is confidential and may not be given (in whole or part) or otherwise distributed to any other third party without the prior written consent of NatWest Markets.

 

NatWest Markets and its affiliates, connected companies, employees or clients may have an interest in financial instruments of the type described in this material and/or in related financial instruments giving rise to potential conflicts of interest which may impact the performance of such financial instruments. Such interests may include, but are not limited to, (a) dealing in, trading, holding or acting as market-maker or liquidity provider in such financial instruments and any reference obligations; (b) entering into hedging strategies on behalf of issuer clients and their affiliates, investor clients or for itself or its affiliates and connected companies; and (c) providing banking, credit and other financial services to any company or issuer of securities or financial instruments referred to herein. NatWest Markets and its affiliates, connected companies, employees or clients may at any time acquire, hold or dispose of long or short positions (including hedging and trading positions) which may impact the performance of a financial instrument.    

 

This material may relate to over-the-counter derivatives (“OTC Derivatives”) in which case you should be aware that OTC Derivatives can provide benefits but may also involve a variety of significant risks. All OTC Derivatives involve risks which include (among other things) the risk of adverse or unanticipated market, financial or political developments, risks relating to the counterparty, liquidity and other risks of a complex character. In the event that such risks arise, substantial costs and/or losses may be incurred and operational risks may arise in the event that appropriate internal systems and controls are not in place. Therefore you should also determine whether OTC Derivatives are appropriate for you given your objectives, experience, financial and operational resources, and other relevant circumstances.

 

If you enter into an OTC Derivative transaction and decide to close out the transaction, or the transaction otherwise terminates before its scheduled termination date, you may have to pay break costs. These will be calculated by reference to prevailing market conditions and include any costs incurred by NatWest Markets in terminating any related financial instrument or trading position. Please note that such break costs can be substantial. If you enter into an OTC Derivative transaction for the purposes of hedging a loan or other debt and you subsequently wish to repay the debt (whether through refinancing or otherwise), you should be aware that it may be necessary for NatWest Markets to terminate the hedging transaction before its scheduled termination date and satisfy any liabilities that you may have to it with respect to such transaction (including break costs) before NatWest Markets will release any related security that you have provided to it.

 

This material has been prepared for information purposes only, does not constitute an analysis of all potentially material issues and is subject to change at any time without prior notice. NatWest Markets does not undertake to update you of such changes. It is indicative only and is not binding. Other than as indicated, this document has been prepared on the basis of publicly available information believed to be reliable but no representation, warranty, undertaking or assurance of any kind, express or implied, is made as to the adequacy, accuracy, completeness or reasonableness of this material, nor does NatWest Markets accept any obligation to any recipient to update, correct or determine the reasonableness of such information or assumptions contained herein. NatWest Markets and each of its respective affiliates accepts no liability whatsoever for any direct, indirect or consequential losses (in contract, tort or otherwise) arising from the use of this material or reliance on the information contained herein. However this shall not restrict, exclude or limit any duty or liability to any person under any applicable laws or regulations of any jurisdiction which may not lawfully be disclaimed.

 

In the U.S., this material, to the extent it relates to securities, is intended for distribution only to major institutional investors as defined in Rule 15a-6 of the U.S. Securities Exchange Act of 1934 as amended (excluding documents produced by our affiliates within the U.S. which are subject to the following disclaimer https://www.agilemarkets.com/api/ds/v1/d isclaimer/publication/2756). This material is not intended as an offer or the solicitation of an offer to buy or sell securities as defined under U.S. securities laws.

 

Notwithstanding the foregoing (but subject to any applicable federal or state securities laws), NatWest Markets and the recipient may disclose to any and all persons, without limitation, the tax treatment and tax structure of any transaction contemplated hereby and all materials (including opinions or other tax analyses) relating thereto. IRS Circular 230 Disclosure: NatWest Markets does not provide tax advice. Accordingly, any discussion of U.S. tax matters contained herein (including any attachments) is not intended or written to be used, and cannot be used, in connection with the promotion, marketing or recommendation by anyone unaffiliated with NatWest Markets of any of the matters addressed herein or for the purpose of avoiding U.S. tax-related penalties.

 

NatWest Markets Plc is authorised by the Prudential Regulation Authority and regulated by the Financial Conduct Authority and Prudential Regulation Authority and is provisionally registered as a swap dealer with the United States Commodity Futures Commission. NatWest Markets N.V. is incorporated with limited liability in the Netherlands, authorised by De Nederlandsche Bank and regulated by De Nederlandsche Bank and the Autoriteit Financiële Markten. It has its seat at Amsterdam, the Netherlands, and is registered in the Commercial Register under number 33002587. Registered Office: Claude Debussylaan 94, Amsterdam, the Netherlands. Branch Reg No. in England BR001029. Agency agreements exist between different members of NatWest Group. Securities business in the United States is conducted through NatWest Markets Securities Inc., a FINRA registered broker-dealer (http://www.finra.org), a SIPC member (www.sipc.org) and a wholly owned indirect subsidiary of NatWest Markets Plc. NatWest Markets Securities Inc. is authorised by NatWest Markets Plc to act as its agent for certain kinds of its activities.

 

 

Copyright © NatWest Markets Plc. All rights reserved.